<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>9 Academy | Waller Combs | Activity</title>
	<link>http://9.academy/members/paincement69/activity/</link>
	<atom:link href="http://9.academy/members/paincement69/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Waller Combs.</description>
	<lastBuildDate>Tue, 03 Nov 2026 18:42:39 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=10.2.0</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">83cd4515bf23e0d6df511aa442bf3295</guid>
				<title>Waller Combs posted an update: 000). For the Asian inhabitants Takinib , S-1-based [&#133;]</title>
				<link>http://9.academy/activity/p/45998/</link>
				<pubDate>Sat, 10 Sep 2022 14:28:30 +0000</pubDate>

									<content:encoded><![CDATA[<p>000). For the Asian inhabitants <a href="https://www.selleckchem.com/products/takinib.html" rel="nofollow ugc">Takinib</a> , S-1-based treatments substantially improved OS along with PFS that has been enhanced ORR in comparison to S-1 monotherapy. The protection report ended up being less well off in patients together with S-1-based treatments, but may be sizeable between your S-1-based therapy along with S-1 monotherapy team.&hellip;<span class="activity-read-more" id="activity-read-more-45998"><a href="http://9.academy/activity/p/45998/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ead73c865fc40bf5c1dbfd9c3a356f30</guid>
				<title>Waller Combs became a registered member</title>
				<link>http://9.academy/activity/p/45935/</link>
				<pubDate>Sat, 10 Sep 2022 14:15:06 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>